Seminars in Hematology
Volume 41, Issue 4 , Pages 287-296, October 2004

Gene therapy of the hemophilias

  • Jay Lozier

      Affiliations

    • Food and Drug Administration Center for Biologics Evaluation and Research, Rockville, MD USA
    • Corresponding Author InformationAddress correspondence to Jay Lozier, MD, PhD, Senior Staff Fellow, FDA Center for Biologics Evaluation and Research, 1401 Rockville Pike HFM 340, Rockville, MD 20852-1448

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 The views expressed in this article are those of the author do not constitute FDA or US Federal Government policy.

PII: S0037-1963(04)00128-3

doi:10.1053/j.seminhematol.2004.07.005

Seminars in Hematology
Volume 41, Issue 4 , Pages 287-296, October 2004

Article Tools

* Image Usage & Resolution